Brief: Anebulo Pharmaceuticals, Inc. Q3 Basic EPS USD -0.04
May 13 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O: ANEBULO PHARMACEUTICALS, INC. Q3 BASIC EPS USD -0.04 ANEBULO PHARMACEUTICALS, INC. Q3 OPERATING EXPENSES USD 1.9 MILLION ANEBULO PHARMACEUTICALS, INC. Q3 NET INCOME USD -1.7 MILLION ANEBULO PHARMACEUTICALS, INC. Q3 EPS USD -0.04 Source text: ID:nBwGwTs2a Further company coverage: ANEB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results